Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Zheng, Meijuan, Gao, Yong, Wang, Gang, Song, Guobin, Liu, Siyu, Sun, Dandan, Xu, Yuanhong, Tian, Zhigang·2020·Cellular & Molecular Immunology

Cited by (1,000)

Items 801–900 of 1,000

  1. Will a little change do you good? A putative role of polymorphisms in COVID-19
    Adriana Alves Oliveira Paim, Ágata Lopes-Ribeiro, Danielle Soares de Oliveira Daian e Silva, Luis Adan Flores Andrade, Thaís de Fátima Silva Moraes, Edel Figueiredo Barbosa‐Stancioli, Flávio Guimarães da Fonseca, Jordana Grazziela Alves Coelho-dos-Reis · 2021 · Immunology Letters
  2. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D
    Hana M. A. Fakhoury, Peter R. Kvietys, Ismail Mohammed Shakir, Hashim Shams, William Burgess Grant, Khaled Manae AlKattan · 2021 · Nutrients
  3. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant Recipients
    Victor H. Ferreira, Tina M. Marinelli, Matthew Ierullo, Terrance Ku, Victoria G. Hall, Beata Majchrzak-Kita, Vathany Kulasingam, Atul Humar, Deepali Kumar · 2021 · The Journal of Infectious Diseases
  4. Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19
    Ivo Udovičić, Ivan Stanojević, Dragan Djordjevic, Snježana Zeba, Goran Rondović, Tanja Abazovic, Srdjan Lazic, Danilo Vojvodić, Kendrick To, Džihan Abazović et al. · 2021 · Journal of Clinical Medicine
  5. The nervous system during COVID ‐19: Caught in the crossfire
    Nick R. Natale, John R. Lukens, William A. Petri · 2022 · Immunological Reviews
  6. Can iron, zinc, copper and selenium status be a prognostic determinant in COVID-19 patients?
    Ayşe Başak Engin, Doruk Engin, Atilla Engin · 2022 · Environmental Toxicology and Pharmacology
  7. Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
    Doris Loh, Russel Joseph Reiter · 2022 · International Journal of Molecular Sciences
  8. A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Mengni Guo, Jieying Liu, Ruoyu Miao, Zohaib Ahmed, James B. Yu, Jian Guan, Sarfraz Ahmad, Shuntai Zhou, Angela Grove, Manoucher Manoucheri et al. · 2022 · Journal of Immunotherapy
  9. Bioorthogonal Photoreactive Surfaces for Single-Cell Analysis of Intercellular Communications
    Takahiro Kosaka, Satoshi Yamaguchi, Shin Izuta, Shinya Yamahira, Yoshikazu Shibasaki, Hiroaki Tateno, Akimitsu Okamoto · 2022 · Journal of the American Chemical Society
  10. COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
    Simon Moubarak, Diala Merheb, Lynn Basbous, Nathalie Chamseddine, Maroun Bou Zerdan, Hazem I. Assi · 2022 · Journal of International Medical Research
  11. Coordinated Loss and Acquisition of NK Cell Surface Markers Accompanied by Generalized Cytokine Dysregulation in COVID-19
    Maria O. Ustiuzhanina, Julia D. Vavilova, Anna A. Boyko, Maria A. Streltsova, Sofya A. Kust, Leonid M. Kanevskiy, Alexander M. Sapozhnikov, Rustam N. Iskhakov, Ekaterina O. Gubernatorova, Marina S. Drutskaya et al. · 2023 · International Journal of Molecular Sciences
  12. Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence
    Izabela Bolesławska, Magdalena Kowalówka, Natasza Bolesławska-Król, Juliusz Przysławski · 2023 · Viruses
  13. Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity
    Martin Potts, Alice Fletcher-Etherington, Katie Nightingale, Federica Mescia, Laura Bergamaschi, Fernando J. Calero‐Nieto, Robin Antrobus, James C. Williamson, Harriet T. Parsons, Edward L. Huttlin et al. · 2023 · Cell Reports
  14. Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
    Jordan A. Hartmann, Marcella Regina Cardoso, Maria Cecília Ramiro Talarico, Devin Kenney, Madison R. Leone, Dagny C. Reese, Jacquelyn Turcinovic, Aoife Kateri O’Connell, Hans P. Gertje, Caitlin Marino et al. · 2024 · Cell
  15. Immune-Mediated Coagulopathy in COVID-19 Infection
    Zahava Vadasz, Benjamin Brenner, Elias Toubi · 2020 · Seminars in Thrombosis and Hemostasis
  16. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2–Induced Cytokine Storm
    Alexandre Eduardo Nowill, Pedro Otavio de Campos-Lima · 2020 · The Journal of Immunology
  17. A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019
    Ludovico De Stefano, Francesca Bobbio‐Pallavicini, Antonio Manzo, Carlomaurizio Montecucco, Serena Bugatti · 2020 · Frontiers in Immunology
  18. Epidemiological investigation and intergenerational clinical characteristics of 24 coronavirus disease patients associated with a supermarket cluster: a retrospective study
    Suochen Tian, Min Wu, Zhenqin Chang, Yunxia Wang, Guijie Zhou, Wenming Zhang, Junmin Xing, Hui Tian, Xihong Zhang, Xiuli Zou et al. · 2021 · BMC Public Health
  19. Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge
    Nima Rezaei, Saboura Ashkevarian, Mahsa Keshavarz Fathi, Sara Hanaei, Zahra Kolahchi, Seyedeh‐Sanam Ladi‐Seyedian, Elham Rayzan, Mojdeh Sarzaeim, Aida Vahed, Kawthar Mohamed et al. · 2021 · Advances in experimental medicine and biology
  20. Innate lymphoid cells (ILC) in SARS-CoV-2 infection
    Amrita Kumar, Weiping Cao, Kedan Endrias, Suresh Varma Kuchipudi, Suresh K. Mittal, Suryaprakash R. Sambhara · 2021 · Molecular Aspects of Medicine
  21. The systemic immunosuppressive effects of peripheral corticosteroid injections: A narrative review of the evidence in the context of COVID‐19
    Paul Regan, Shuayb Elkhalifa, Paul Barratt · 2021 · Musculoskeletal Care
  22. A Real Pandora’s Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19
    Amalia Stefana Țimpău, Radu-Ştefan Miftode, Daniela A. Leca, Razvan Timpau, Ionela-Larisa Miftode, Antoniu Octavian Petriş, Irina Iuliana Costache, Ovidiu Mitu, Ana Nicolae, Alexandru Florinel Oancea et al. · 2022 · Life
  23. Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories
    Yapeng Su, Daniel Chen, Christopher G. Lausted, Dan Yuan, Jongchan Choi, Chengzhen L. Dai, Valentin Voillet, Kelsey Scherler, Pamela Troisch, Venkata R. S. K. Duvvuri et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  24. CD8 + T cells mediate antiviral response in severe fever with thrombocytopenia syndrome
    Lu Zong, Fan Yang, Siyu Liu, Yufeng Gao, Fang Xia, Meijuan Zheng, Yuanhong Xu · 2022 · The FASEB Journal
  25. Potential approaches to combat COVID-19: a mini-review
    Zainab Sarwar, Tahir Ahmad, Salik Javed Kakar · 2020 · Molecular Biology Reports
  26. Medicinal Plants as COVID-19 Remedy
    Sara Zafar, Shagufta Perveen, Naeem Iqbal, Muhammad Kamran Khan, Modhi Obaidan Alotaibi, Afrah Eltayeb Mohammed · 2021 · Springer eBooks
  27. The transcription factor Eomes promotes expression of inhibitory receptors on hepatic CD8 + T cells during HBV persistence
    Linyan Yu, Yun Guan, Lei Li, Nan Lü, Cai Zhang · 2022 · FEBS Journal
  28. Association of vitamin D status with COVID‐19 disease severity in pediatric patients: A retrospective observational study
    Solmaz Heidari, Shooka Mohammadi, Mohammadreza Fathi, Shayan Cigary, Mohsen Alisamir, Mohammadreza Mirkarimi, Majid Aminzadeh · 2022 · Health Science Reports
  29. Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA
    Grant R. Campbell, Pratima Rawat, Stephen A. Spector · 2022 · Journal of Innate Immunity
  30. Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission
    Sergio Gil-Manso, Diego Herrero-Quevedo, Diego Carbonell, Marta Martínez‐Bonet, Esther Bernaldo-de-Quirós, Rebeca Kennedy-Batalla, Jorge Gallego-Valle, Rocío López-Esteban, Elena Blázquez‐López, Iria Miguéns-Blanco et al. · 2023 · PLoS Pathogens
  31. Immunosenescence and Inflammaging in COVID-19
    Faezeh Asghari, Amir Asghary, Naime Majidi Zolbanin, Fatemeh Faraji, Reza Jafari · 2023 · Viral Immunology
  32. Cytokine storm and translating IL-6 biology into effective treatments for COVID-19
    Tiantian Li, Dongsheng Wang, Haiming Wei, Xiaoling Xu · 2023 · Frontiers of Medicine
  33. COVID-19 Detection via Wavelet Entropy and Biogeography-Based Optimization
    Xujing Yao, Ji Han · 2020 · Lecture notes on data engineering and communications technologies
  34. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids
    Marta Trevisan, Silvia Riccetti, Alessandro Sinigaglia, Luisa Barzon · 2021 · International Journal of Molecular Sciences
  35. Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients
    Igor Age Kos, Benedikt Balensiefer, Vadim Lesan, Dominic Kaddu‐Mulindwa, Lorenz Thurner, Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Manfred Ahlgrimm, Martina Seiffert, Stefan Wagenpfeil et al. · 2021 · European Journal of Immunology
  36. Clinical characteristics of older patients with COVID-19: a systematic review of case reports
    Luisser Dainner Saavedra Córdova, Alexander Mayor-Vega, Elmer Luján-Carpio, Jose Francisco Parodi, Enrique Moncada–Mapelli, Isai Armacanqui-Valencia, Jhonatanael Salvador-Ruiz, Dalia Pawer, Erickson Ydrogo-Cruz, Mylenka Jennifer Chevarría-Arriaga et al. · 2021 · Dementia & Neuropsychologia
  37. The Many Faces of Innate Immunity in SARS-CoV-2 Infection
    Nicholas Hanan, Ronnie L. Doud, In-Woo Park, Harlan P. Jones, Stephen O. Mathew · 2021 · Vaccines
  38. Metabolic reprogramming and immune regulation in viral diseases
    Goutham V. Ganesh, Kunka Mohanram Ramkumar · 2021 · Reviews in Medical Virology
  39. Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology
    Amy Susan Codd, Stephanie Jean Hanna, Ewoud Bernardus Compeer, Felix Clemens Richter, Eleanor J. Pring, Ester Gea-Mallorquí, Mariana Borsa, Owen R. Moon, David Oliver Scourfield, David Ahern et al. · 2021 · Oxford Open Immunology
  40. Cardiovascular Disease Complicating COVID-19 in the Elderly
    Christopher Dayaramani, Joshua De Leon, Allison Bethanne Reiss · 2021 · Medicina
  41. SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly
    Anna Onnis, Emanuele Andreano, Chiara Cassioli, Francesca Finetti, Chiara Della Bella, Oskar Staufer, Elisa Pantano, Valentina Abbiento, Giuseppe Marotta, Mario Milco D’Elios et al. · 2022 · The Journal of Experimental Medicine
  42. Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c
    Ludger Klimek, Oliver Pfaar, Margitta Worm, Karl‐Christian Bergmann, Thomas R.M. Bieber, Roland Buhl, Jeroen Buters, Ulf Darsow, Thomas Oskar Philipp Keil, Jörg Kleine‐Tebbe et al. · 2020 · Allergo Journal
  43. High‐fluorescent lymphocytes are increased in patients with COVID‐19
    Zhao Wang, Yu He, Huaqing Shu, Ping Wang, Hui Xing, Xiaoqian Zeng, Zhaoming Tang · 2020 · British Journal of Haematology
  44. Use of nanotechnology in combating coronavirus
    Saee Gharpure, Balaprasad G Ankamwar · 2021 · 3 Biotech
  45. The link between Toxoplasma gondii infections and higher mortality in COVID-19 patients having schizophrenia
    Kevin Roe · 2021 · European Archives of Psychiatry and Clinical Neuroscience
  46. Post-COVID fungal infections of maxillofacial region: a systematic review
    Anuj Jain, Saumya Taneja · 2021 · Oral and Maxillofacial Surgery
  47. COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections
    Nathalie Schwab, Ronny Nienhold, Maurice Johannes Henkel, Albert Baschong, Anne Graber, Angela Frank, Nadine Mensah, Jacqueline Koike, Claudia Hernach, Melanie Sachs et al. · 2022 · Frontiers in Medicine
  48. Reactivation of Herpes Zoster Virus After COVID-19 Vaccination: Is There Any Association?
    Surbhi Agrawal, Kapila Verma, Ishan Verma, Jagriti Gandhi · 2022 · Cureus
  49. Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies
    Songfeng Wu, Yuan Xu, Jian Zhang, Xiaoju Ran, Xue Jia, Jing Wang, Longqin Sun, Huan Yang, Yulei Li, Bin Fu et al. · 2022 · Frontiers in Immunology
  50. Development of Single-Cell Transcriptomics and Its Application in COVID-19
    Chaochao Wang, Ting Huyan, Xiaojie Zhou, Xuanshuo Zhang, Suyang Duan, Shan Gao, Shanfeng Jiang, Qi Li · 2022 · Viruses
  51. Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
    Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, Luca Marsili, Anne Michele Slavotinek, Daniel R. Prows, Robert James Hopkin, Mary Ashley McKay, Manoj K. Pandey · 2022 · International Journal of Molecular Sciences
  52. An Attention towards the Prophylactic and Therapeutic Options of Phytochemicals for SARS-CoV-2: A Molecular Insight
    Shoaib Shoaib, Mohammad Azam Ansari, Geetha Kandasamy, Rajalakshimi Vasudevan, Umme Hani, Waseem Chauhan, Maryam S. Alhumaidi, Khadijah A. Altammar, Sarfuddin Azmi, Wasim Ahmad et al. · 2023 · Molecules
  53. Increased NKG2A+CD8+ T-cell exhaustion in patients with adenomyosis
    Wei Liu, Shuman Sheng, Chendi Zhu, Changzhong Li, Yonghui Zou, Chunrun Yang, Zi‐Jiang Chen, Fei Wang, Xue Jiao · 2023 · Mucosal Immunology
  54. Advanced flow cytometry for biomedical applications
    Kai Pang, Sihan Dong, Yuxi Zhu, Xi Zhu, Quanyu Zhou, Bobo Gu, Wei Jin, Rui Zhang, Yuting Fu, Bingcheng Yu et al. · 2023 · Journal of Biophotonics
  55. New perspective on the immunomodulatory activity of ginsenosides: Focus on effective therapies for post-COVID-19
    Yixin Wang, Qin Han, Shuxia Zhang, Xiaoyan Xing, Xiaobo Sun · 2023 · Biomedicine & Pharmacotherapy
  56. Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19
    Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Zahra Sadat Hashemi, Hassan Sanati, Fereshteh Abbasvandi, Masud Yunesian, Keivan Majidzadeh‐A, Jalil Makarem, Hamid Reza Aghayan, Atefeh Abedini et al. · 2023 · Pilot and Feasibility Studies
  57. COVID-19 pathophysiology: A review
    Liqiang Zhou, Shuxing Xing · 2024 · International Journal of Clinical Medical Research
  58. Late-onset Systemic Lupus Erythematosus
    Prakashini Mruthyunjaya, Sakir Ahmed, Aliya Botabekova, Chokan Baimukhamedov, Olena Zimba · 2025 · Rheumatology International
  59. SARS-CoV-2 y sistema inmune: una batalla de titanes
    Universidad de San Martín de Porres, Facultad de Medicina Humana, Instituto de Investigación, Centro de Investigación de Infectología e Inmunología. Lima, Perú, Joel de León, Arturo Pareja Cruz, Universidad de San Martín de Porres, Facultad de Medicina Humana, Instituto de Investigación, Centro de Investigación de Infectología e Inmunología. Lima, Perú, Priscilia Aguilar Ramírez, Universidad de San Martín de Porres, Facultad de Medicina Humana, Instituto de Investigación, Centro de Investigación de Infectología e Inmunología. Lima, Perú, Yanina Enriquez Valencia, Universidad de San Martín de Porres, Facultad de Medicina Humana, Instituto de Investigación, Centro de Investigación de Infectología e Inmunología. Lima, Perú, Carlos Carrillo, Universidad de San Martín de Porres, Facultad de Medicina Humana, Instituto de Investigación, Centro de Investigación de Infectología e Inmunología. Lima, Perú et al. · 2020 · Horizonte Médico (Lima)
  60. Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19
    Pascal H. G. Duijf · 2020 · mSystems
  61. Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy
    Yukihiro Shimizu · 2020 · World Journal of Clinical Cases
  62. RETRACTED: SBracing NK cell based therapy to relegate pulmonary inflammation in COVID-19
    Madhan Jeyaraman, Sathish Muthu, Asawari Bapat, Rashmi Jain, Sushmitha ES, Arun Gulati, Talagavadi Channaiah Anudeep, Shirodkar Jaswandi Dilip, Niraj Kumar Jha, Dhruv Kumar et al. · 2021 · Heliyon · Retracted
  63. SARS-CoV-2: Overview and Its Impact on Oral Health
    Miriam Ting, Jon B. Suzuki · 2021 · Biomedicines
  64. Potential metal‐related strategies for prevention and treatment of COVID‐19
    Yaqiong Ni, Huihui Zeng, Xianwen Song, Jun Zheng, Hui‐Qiong Wu, Chuntai Liu, Yi Zhang · 2022 · Rare Metals
  65. In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production
    Alessandra Imeneo, Grazia Alessio, Andrea Di Lorenzo, Laura Campogiani, Alessandra Lodi, Filippo Barreca, Marta Zordan, Virginia Barchi, Barbara Massa, Simona Tedde et al. · 2022 · Life
  66. Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients
    Christophe Capelle, Séverine Ciré, Olivia Domingues, Isabelle Ernens, Fanny Hedin, Aurélie Fischer, Chantal J. Snoeck, Wim Ammerlaan, Maria Konstantinou, Kamil Grzyb et al. · 2022 · Cell Reports Medicine
  67. Principles Learned from the International Race to Develop a Safe and Effective COVID-19 Vaccine
    Ariel Helms Thames, Kristy Lucile Wolniak, Samuel Isaac Stupp, Michael C. Jewett · 2020 · ACS Central Science
  68. Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic
    Hongxin Yu, Chunyan Li, Xing Wang, Jingyi Duan, Na Yang, Lijuan Xie, Yuan Yu, Shanze Li, Chenghao Bi, Bin Yang et al. · 2020 · Journal of Proteome Research
  69. Analysis of SARS-CoV-2 specific T-cell receptors in ImmuneCode reveals cross-reactivity to immunodominant Influenza M1 epitope
    John-William Sidhom, Alexander Spyridon Baras · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Acute SARS-CoV-2 infection
    Amy C Sherman, Glenda Gray, Bin Cao, Kelvin Kai‐Wang To, Nadine Rouphael, Ana Maria Henao Restrepo, Anthony C. Gordon, Lindsey Robert Baden · 2025 · Nature Reviews Disease Primers
  71. Inflammation, a Common Mechanism in Frailty and COVID-19, and Stem Cells as a Therapeutic Approach
    José Becerra, Iván Durán · 2021 · Stem Cells Translational Medicine
  72. “Acute” monoclonal gammopathy in severe COVID-19
    Natale Vazzana, Silvia Ognibene, Francesco Dipaola · 2020 · Hematology Transfusion and Cell Therapy
  73. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges
    Mahsa Hajivalili, Maryam Sadat Hosseini, Mostafa Haji-Fatahaliha · 2020 · Life Sciences
  74. Blood cell counts and lymphocyte subsets of patients admitted during the COVID‐19 pandemic: a prospective cohort study
    Paul J. Hengeveld, Aaram Omar Khader, Linda H. A. de Bruin, Inge G.P. Geelen, Eske A. van Baalen, Eva Jansen, Nathalie I. Bouwer, Ömer Balak, Jürgen Riedl, Anton W. Langerak et al. · 2020 · British Journal of Haematology
  75. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure
    Suparno Chakrabarti · 2020 · Mediterranean Journal of Hematology and Infectious Diseases
  76. Characterization of KIR + NKG2A + Eomes− NK‐like CD8+ T cells and their decline with age in healthy individuals
    Dimitri Kasakovski, Xiangbo Zeng, Jing Lai, Zhi Hui Yu, Danlin Yao, Shaohua Chen, Xianfeng Zha, Yangqiu Li, Ling Xu · 2020 · Cytometry Part B Clinical Cytometry
  77. Uremia-Associated Immunological Aging and Severity of COVID-19 Infection
    Michiel G.H. Betjes · 2021 · Frontiers in Medicine
  78. Role of the Immune Microenvironment in SARS-CoV-2 Infection
    Chih-Hung Ye, Wen‐Lin Hsu, Guan-Ru Peng, Wei-Chieh Yu, Weichen Lin, SuiYun Hu, Shu‐Han Yu · 2021 · Cell Transplantation
  79. The Potential Role of an Aberrant Mucosal Immune Response to SARS-CoV-2 in the Pathogenesis of IgA Nephropathy
    Zhao Zhang, Guorong Zhang, Meng Guo, Wanyin Tao, Xingzi Liu, Haiming Wei, Tengchuan Jin, Yuemiao Zhang, Shu Zhu · 2021 · Pathogens
  80. COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators
    Mina Thabet Kelleni · 2021 · Immunologic Research
  81. Implications of Vitamins in COVID-19 Prevention and Treatment through Immunomodulatory and Anti-Oxidative Mechanisms
    Juan M. Toledano, Jorge Moreno‐Fernández, María Puche-Juárez, Julio José Ochoa, Javier Díaz‐Castro · 2021 · Antioxidants
  82. Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19
    Carlos Jiménez‐Cortegana, Flora Sánchez-Jiménez, Antonio Pérez‐Pérez, Nerissa Álvarez, Alberto Sousa, María Luisa Cantón‐Bulnes, Teresa Vilariño‐García, Sandra Fuentes, Salomón Martín Pérez, Marta Jiménez et al. · 2022 · Frontiers in Immunology
  83. COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches
    Mahdi Zavvar, Aisan Yahyapoor, Hamed Baghdadi, Sina Zargaran, Sara Assadiasl, Kamal Abdolmohammadi, Amir Hossein Abooei, Mohammad Reza Sattarian, Melina JalaliFarahani, Negar Zarei et al. · 2022 · International Immunopharmacology
  84. Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
    Hatixhe Latifi-Pupovci · 2022 · Biomedicine & Pharmacotherapy
  85. Combined systemic inflammatory indexes as reflectors of outcome in patients with COVID‑19 infection admitted to ICU
    Amir Tahavvori, Reza Mosaddeghi-Heris, Faezeh Ghanbari Sevari, Seyed Mohammad Amin Alavi, Peghah Panahi, Niloufar Abbasi, Hamed Rahmani Youshanlouei, Seyyed Sina Hejazian · 2023 · Inflammopharmacology
  86. The Good, The Bad and The Ugly: A Mathematical Model Investigates the Differing Outcomes Among CoVID-19 Patients
    Sarthak Sahoo, Siddharth Jhunjhunwala, Mohit Kumar Jolly, Mohit Kumar Jolly · 2020 · Journal of the Indian Institute of Science
  87. Jinhua Qinggan granule, a Chinese herbal medicine against COVID‑19, induces rapid changes in the neutrophil/lymphocyte ratio and plasma levels of IL‑6 and IFN‑γ: An open‑label, single‑arm pilot study
    Yasunari Kageyama, Koichi Aida, Kimihiko Kawauchi, Masafumi Morimoto, Tomoka Ebisui, Tetsu Akiyama, Tsutomu Nakamura · 2021 · World Academy of Sciences Journal
  88. T-cell exhaustion in COVID-19: what do we know?
    Roderick Chen-Camaño, Rodrigo DeAntonio, Sandra López‐Vergès · 2025 · Frontiers in Immunology
  89. Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals
    Nadejda Beliakova‐Bethell, Kathirvel Maruthai, Ruijie Xu, Liliana C. M. Salvador, Ankita Garg · 2022 · Frontiers in Immunology
  90. Natural Products as a Potential Source of Promising Therapeutics for COVID‐19 and Viral Diseases
    Soheila Bafandeh, Ehsaneh Khodadadi, Khudaverdi Ganbarov, Mohammad Asgharzadeh, Şükran Köse, Hossein Samadi Kafil · 2023 · Evidence-based Complementary and Alternative Medicine
  91. NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins
    Ilya Tsukalov, Ildefonso Sánchez‐Cerrillo, Olga Rajas, Elena Ávalos, Gorane Iturricastillo, Laura Esparcia, Maria José Buzón, Meritxell Genescà, Camila Scagnetti, Olga Popova et al. · 2024 · Nature Communications
  92. Immunoregulatory natural killer cells
    Kevin Roe · 2024 · Clinica Chimica Acta
  93. The COVID-19 pandemic: catching up with the cataclysm
    Surajit Chakraborty, Anirban Basu · 2020 · F1000Research
  94. Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection
    Jingyi Yang, Ejuan Zhang, Maohua Zhong, Qingyu Yang, Ke Hong, Ting Shu, Dihan Zhou, Jie Xiang, Jianbo Xia, Xi Zhou et al. · 2020 · Virologica Sinica
  95. Illuminating the immunopathology of SARS‐CoV ‐2
    Suraj Saksena, Pratip K. Chattopadhyay · 2021 · Cytometry Part B Clinical Cytometry
  96. The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia
    Ali Abdullah Almontasheri, Faisal Al-Husayni, Anas Khaleel Alsuraihi, Hanan Binyahib, Amr S. Albanna · 2021 · American Journal of Case Reports
  97. Early identification of patients with severe COVID-19 at increased risk of in-hospital death: a multicenter case-control study in Wuhan
    Wei Zhou, Yisi Liu, Beibei Xu, Sa Wang, Shusheng Li, Hong Shu Liu, Zi-Ting Huang, Yan Luo, Ming Hu, Wenjuan Wu et al. · 2021 · Journal of Thoracic Disease
  98. Update on Immunology of COVID-19 Disease and Potential Strategy for Controlling.
    Neda K. Dezfuli, Ian Michael Adcock, Nooshin Montazami, Esmaeil Mortaz, Ali Akbar Velayati · 2020 · PubMed Central
  99. The Immunopathobiology of SARS-CoV-2 Infection
    Milankumar Patel, Farah Shahjin, Jacob D. Cohen, Mahmudul Hasan, Jatin Machhi, Heerak Chugh, Snigdha Singh, Srijanee Das, Tanmay A. Kulkarni, Jonathan Herskovitz et al. · 2021 · FEMS Microbiology Reviews
  100. Efficacy of phytochemicals as immunomodulators in managing COVID-19: a comprehensive view
    Sonali Bhattacharya, Sudipta Majumdar nee Paul · 2021 · VirusDisease